# Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction

Study · id `cardio:ct-nct05604976` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05604976](<https://clinicaltrials.gov/study/NCT05604976>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05604976

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 430 participants.

## Technical summary

Registry record NCT05604976. Randomized; no masking; primary purpose treatment. Start 2022-11-01 (actual); primary completion 2024-12-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 430 participants (planned count; ClinicalTrials.gov record NCT05604976, source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)
- Started: 2022-11-01 (actual) (ClinicalTrials.gov record NCT05604976, source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)
- Primary completion: 2024-12-20 (anticipated) (ClinicalTrials.gov record NCT05604976, source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)
- Completion: 2025-12-20 (anticipated) (ClinicalTrials.gov record NCT05604976, source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT05604976, source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05604976-2023-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction
- Acronym: SPEEDYPCI
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): Percutaneous coronary intervention
- Lead sponsor: Tokai University
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: cff3304705a780428bc550ee8aa7c2dfa227c364bf15d33010be841d96e04f96
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
